doi:10.1515/9783111510828-118
Canada Europe Germany UK France Italy Spain Netherlands Asia Pacific China India Japan Australia South Korea Latin America Brazil Mexico Argentina Middle East and Africa Saudi Arabia South Africa UAE Table of Contents Chapter 1 Methodology and Scope Chapter 2 Executive Summary Chapter 3 Industry Insights Chapter 4 Competitive Landscape, 2025 Chapter 5 Market Estimates and Forecast, By Drug Type, 2022 2035 ($ Mn) Chapter 6 Market Estimates and Forecast, By Route of Administration, 2022 2035 ($ Mn) Chapter 7 Market Estimates and Forecast, By Indication, 2022 2035 ($ Mn) Chapter 8 Market Estimates and Forecast, By Distribution Channel, 2022 2035 ($ Mn) Chapter 9 Market Estimates and Forecast, By Region, 2022 2035 ($ Mn) Chapter 10 Company Profiles Don't see your key competitors
Prevalence of use and interest in using glucagon-like peptide-1 receptor agonists for weight loss: a population study in Great Britain
Otimiza o rendimento fsico e a recuperao , favorecendo o suporte massa magra e auxiliando o organismo no ps-treino
These participants were split into six groups and each group received a different amount of the medicine: 1
1991 Breningstall GN: Carnitine deficiency syndromes